AngioDynamics Set to Show Whether Business Momentum Can Finally Match the Recent Price Recovery
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
AngioDynamics typically reports earnings before market open, meaning Day 0 represents the first full trading session where investors react to results, while Day +1 captures follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-07-14 | +$0.22 (+1.76%) | $1.33 (10.41%) | +$1.47 (+11.31%) | $1.96 (15.04%) |
| 2026-04-02 | -$1.63 (-13.65%) | $1.64 (13.73%) | -$0.47 (-4.56%) | $0.77 (7.47%) |
| 2025-10-02 | +$0.67 (+6.05%) | $1.41 (12.70%) | -$0.10 (-0.85%) | $0.56 (4.77%) |
| 2025-07-15 | -$0.98 (-10.18%) | $2.18 (22.59%) | -$0.05 (-0.58%) | $0.62 (7.11%) |
| 2025-04-02 | +$1.20 (+12.42%) | $1.51 (15.63%) | -$1.04 (-9.58%) | $0.72 (6.68%) |
| 2025-01-08 | +$3.54 (+37.66%) | $1.63 (17.33%) | -$0.64 (-4.95%) | $0.82 (6.34%) |
| 2024-10-03 | -$1.28 (-16.73%) | $0.86 (11.18%) | -$0.27 (-4.24%) | $0.55 (8.63%) |
| 2024-07-16 | N/A | N/A | N/A | N/A |
| Avg Abs Move | 14.07% | 14.80% | 5.15% | 8.00% |
Historical price action around ANGO earnings shows significant volatility, with an average absolute Day 0 move of 14.07% and Day 0 trading range of 14.80%. The most recent July 2026 report was relatively muted with a 1.76% gain on Day 0, but earlier reports triggered dramatic swings—including a 37.66% surge in January 2025 and double-digit moves in both directions throughout 2025.
Day +1 follow-through averages 5.15%, suggesting initial reactions often moderate in the second session. The pattern indicates ANGO is prone to sharp initial moves that can reverse or consolidate quickly. Investors should prepare for potential double-digit percentage swings on earnings day, with the direction heavily dependent on whether the company continues its streak of beating estimates and provides encouraging guidance on the path to profitability.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 10/16/26 (DTE 16) |
| Expected Move | $1.72 (11.16%) |
| Expected Range | $13.66 to $17.10 |
| Implied Volatility | 99.66% |
The options market is pricing an 11.16% expected move for the October 16 expiration, which is below the 14.07% average historical Day 0 move but still reflects elevated volatility expectations. This suggests options traders are anticipating a meaningful reaction, though perhaps less dramatic than some of the extreme moves seen in prior quarters.
Part 3: What Analysts Are Saying
Analyst sentiment on AngioDynamics is mixed, with a consensus rating that translates to "Hold" and a mean price target of $18.60—implying 21.1% upside from the current price of $15.36. The rating breakdown shows 4 Strong Buy ratings and 1 Strong Sell, with no Hold or Moderate Buy/Sell recommendations, creating a polarized view of the stock's prospects.
The sentiment trend is unchanged from a month ago, with the same 4-1 Strong Buy to Strong Sell split maintained. Price target estimates range widely from a low of $13.00 to a high of $24.00, reflecting the divergent views on whether the company's operational improvements justify the recent 83.81% rally over the past year.
The consensus price target of $18.60 suggests analysts see further upside potential despite the stock's strong run, though the presence of a Strong Sell rating and the wide target range indicate significant uncertainty about the sustainability of growth and the timeline to profitability. The unchanged sentiment over the past month suggests analysts are waiting for this earnings report to provide clarity on whether recent momentum can continue.
Part 4: Technical Picture
The Barchart Technical Opinion shows a Buy signal at 80%, down from 100% Buy a month ago, indicating some recent weakening in technical momentum despite the stock's strong year-to-date performance. The signal remained at 80% Buy over the past week, suggesting near-term consolidation.
Timeframe Analysis:
- Short-term (50% Buy): Moderate buy signal indicates near-term momentum has cooled from earlier strength, reflecting recent consolidation around the $15 level
- Medium-term (100% Buy): Strong buy signal confirms the intermediate-term uptrend remains intact, supported by the stock's position well above longer-term moving averages
- Long-term (100% Buy): Strong buy signal reflects the powerful 83.81% rally over the past year and sustained upward trajectory
Trend Characteristics: The Strong trend showing signs of Weakening suggests the stock remains in a solid uptrend but is experiencing near-term consolidation after its dramatic run, creating a cautious setup heading into earnings.
At $15.36, ANGO is trading below its 5-day ($15.45), 10-day ($15.47), and 20-day ($15.43) moving averages, indicating short-term consolidation. However, the stock remains above its 50-day ($15.34), 100-day ($13.81), and 200-day ($12.46) moving averages, confirming the longer-term uptrend is intact. The stock is testing support at its 50-day moving average, a key technical level that could determine whether the uptrend resumes or further consolidation is needed.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $15.45 | 50-Day MA | $15.34 |
| 10-Day MA | $15.47 | 100-Day MA | $13.81 |
| 20-Day MA | $15.43 | 200-Day MA | $12.46 |
The technical setup heading into earnings is cautiously supportive but vulnerable. While the longer-term trend remains bullish with the stock well above its 100-day and 200-day moving averages, the recent pullback below short-term moving averages and weakening near-term momentum suggest limited cushion for disappointment. The 50-day moving average at $15.34 represents critical support—a break below on earnings could trigger further selling, while a beat that reclaims the short-term moving averages could reignite the uptrend. Given the stock's 83.81% year-to-date gain and elevated options-implied volatility, investors should expect significant price movement in either direction based on results and guidance.